Updates

May 21, 2020May 21, 2020
COPD Seen to Raise Risk of Lung Cancer in Non-smokers

Chronic obstructive pulmonary disease (COPD) is linked to a higher risk of lung cancer in people who never smoked. In fact, their risk is ... Read more
May 14, 2020May 14, 2020
Zephyr Valve Eases Breathlessness in Severe Emphysema, Trial Analysis Shows

Pulmonx’s Zephyr Endobronchial Valve significantly reduces breathlessness and improves physical activity and quality of life in people with severe emphysema, a post-hoc analysis of ... Read more
May 7, 2020May 7, 2020
Expansion of Unusual Stem Cell Subsets May Drive COPD Progression, Study Suggests

People with chronic obstructive pulmonary disease (COPD) have three unusual stem cell subsets in their lungs that, together, seem to contribute to the inflammation, ... Read more
April 30, 2020April 30, 2020
Triple Combo Therapy Reduces All-cause Mortality in COPD, Analysis Suggests

Triple therapy with fluticasone furoate (FF), umeclidinium (UMEC), and vilanterol (VI) can reduce mortality rates among people with chronic obstructive pulmonary disease ... Read more
April 28, 2020April 28, 2020
Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak

FFF Enterprises and BioNews announced today that both rare and orphan disease advocates are joining forces to provide patients with resources to help them ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

June 20, 2017June 20, 2017

Tilray Announces Support for Clinical Trial Evaluating Medical Cannabis Efficacy in COPD Patients

News

The effects of vaporized cannabis on symptoms associated with chronic obstructive pulmonary disease (COPD) are the target of a new clinical trial that stems from a partnership between medical cannabis products company Tilray and the Research Institute of the McGill University ... Read more

Updates

COPD Seen to Raise Risk of Lung Cancer in Non-smokers

Zephyr Valve Eases Breathlessness in Severe Emphysema, Trial Analysis Shows

Expansion of Unusual Stem Cell Subsets May Drive COPD Progression, Study Suggests

Triple Combo Therapy Reduces All-cause Mortality in COPD, Analysis Suggests

Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak

Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

American Thoracic Society Issues New Guidelines for COPD Treatments

MP1032 May Protect Lungs From Oxidative Stress, COPD Model Suggests

Lung Association Advises COPD Patients to Keep with Treatments in Pandemic

Ensifentrine, in Pressurized Dose Inhaler, Showing Efficacy in COPD Trial

Pulmonary Fibrosis Patient Spearheads Lung Transplant Foundation to Help Others

Subscribe to our mailing list

COPD Patients Vulnerable to Severe COVID-19 Infections, Study Finds

Low CC16 Protein Levels Linked to COPD Progression, Worse Lung Function in Study

Acid Reflux Linked to Higher Risk of COPD Exacerbations, Review Suggests

Disinfectant Use May Increase Nurses’ Risk of COPD, Study Finds

Coronavirus: What Every Pulmonary Patient Needs to Know!

Signant, Propeller Health to Connect Systems on Inhaler Use Data

Adding Ensifentrine to Tiotropium Therapy Improves Lung Function in COPD, Top-line Results Show

New Pulmonary Wellness Foundation Offers Free Online Rehab Programs

New Combination Respiratory Therapy for COPD Approved by FDA

Certain Cancer Therapies May Hold Promise in Treating COPD, Preclinical Study Suggests

New Assisted Breathing Device May Soon Be Available for Patients with Trouble Breathing

COPD Triple-combination Therapy Approved in China, AstraZeneca Announces

E-cigs Raise Risk of Chronic Lung Disease, Especially in Those Who Also Smoke, Study Finds

Propeller’s Digital Health Tool Eases Provider Burden, Boosts COPD Patient Use, Study Finds

RejuvenAir System Granted CE Mark Approval in Europe to Treat COPD With Chronic Bronchitis

Zephyr Valve Favored as Standard of Care for Eligible COPD Patients in 2020 GOLD Report

For COPD Awareness Month, Be Alert to Dangers of Indoor Air Pollutants, Company Advises

Expanded Diagnostic Criteria Needed for COPD, Study Suggests

Non-invasive Test to Diagnose Genetic Form of COPD Now Available in U.S.

European 3TR Project Unites Experts in Effort to Make Treatment More Personal and Effective

New Canadian National Report Highlights Gaps in COPD Diagnoses, Care

Seasonal Variations of COPD Exacerbations Call for Timely Preventive Measures, Study Suggests

Duaklir Now Available to COPD Patients in US, Circassia Announces

Tudorza Reduces COPD Flare-ups Without Increasing Risk of Cardiovascular Complications or Death, Phase 4 Trial Shows

Tilray Announces Support for Clinical Trial Evaluating Medical Cannabis Efficacy in COPD Patients

Pin It on Pinterest

COPD Seen to Raise Risk of Lung Cancer in Non-smokers

Zephyr Valve Eases Breathlessness in Severe Emphysema, Trial Analysis Shows

Expansion of Unusual Stem Cell Subsets May Drive COPD Progression, Study Suggests

Triple Combo Therapy Reduces All-cause Mortality in COPD, Analysis Suggests

Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak

Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

American Thoracic Society Issues New Guidelines for COPD Treatments

MP1032 May Protect Lungs From Oxidative Stress, COPD Model Suggests

Lung Association Advises COPD Patients to Keep with Treatments in Pandemic

Ensifentrine, in Pressurized Dose Inhaler, Showing Efficacy in COPD Trial

Pulmonary Fibrosis Patient Spearheads Lung Transplant Foundation to Help Others

Subscribe to our mailing list

COPD Patients Vulnerable to Severe COVID-19 Infections, Study Finds

Low CC16 Protein Levels Linked to COPD Progression, Worse Lung Function in Study

Acid Reflux Linked to Higher Risk of COPD Exacerbations, Review Suggests

Disinfectant Use May Increase Nurses’ Risk of COPD, Study Finds

Video: BioNews’ Social Media Campaign Highlights #WhatMakesMeRare

Coronavirus: What Every Pulmonary Patient Needs to Know!

Signant, Propeller Health to Connect Systems on Inhaler Use Data

Adding Ensifentrine to Tiotropium Therapy Improves Lung Function in COPD, Top-line Results Show

New Pulmonary Wellness Foundation Offers Free Online Rehab Programs

New Combination Respiratory Therapy for COPD Approved by FDA

Certain Cancer Therapies May Hold Promise in Treating COPD, Preclinical Study Suggests

New Assisted Breathing Device May Soon Be Available for Patients with Trouble Breathing

COPD Triple-combination Therapy Approved in China, AstraZeneca Announces

E-cigs Raise Risk of Chronic Lung Disease, Especially in Those Who Also Smoke, Study Finds

Propeller’s Digital Health Tool Eases Provider Burden, Boosts COPD Patient Use, Study Finds

RejuvenAir System Granted CE Mark Approval in Europe to Treat COPD With Chronic Bronchitis

Zephyr Valve Favored as Standard of Care for Eligible COPD Patients in 2020 GOLD Report

For COPD Awareness Month, Be Alert to Dangers of Indoor Air Pollutants, Company Advises

Expanded Diagnostic Criteria Needed for COPD, Study Suggests

Non-invasive Test to Diagnose Genetic Form of COPD Now Available in U.S.

European 3TR Project Unites Experts in Effort to Make Treatment More Personal and Effective

New Canadian National Report Highlights Gaps in COPD Diagnoses, Care

Seasonal Variations of COPD Exacerbations Call for Timely Preventive Measures, Study Suggests

Duaklir Now Available to COPD Patients in US, Circassia Announces

Tudorza Reduces COPD Flare-ups Without Increasing Risk of Cardiovascular Complications or Death, Phase 4 Trial Shows

Pin It on Pinterest